arrow
Back
J

John Radford

University of Manchester and The Christie NHS Foundation Trust

87H-index
693Paper Count
3.0WCitation Count
Published Papers 80
Publication Date
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter’s transformation.
err2026-02-09
err0
errOAAI
errKatharine Louise Lewis; Sarit E Assouline; Ross Baker; Nancy L Bartlett; Dima El-Sharkawi; Pratyush Giri; Matthew Ku; Matthew Matasar; Stephen Schuster; John Radford; Michael C Wei; Shen Yin; Antonia Kwan; Iris To; Vibya Raghavan; Lihua E Budde; Chan Y Cheah
errShare
errSave
Camidanlumab Tesirine in Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study
err2025-08-19
err0
errOAAI
errAlex F. Herrera; Stephen M. Ansell; Pier Luigi Zinzani; John Radford; Kami Maddocks; Antonio Pinto; Graham P. Collins; Veronika Bachanova; Nancy L. Bartlett; Isabelle Bence-Bruckler; Mehdi Hamadani; Justin Kline; Jiří Mayer; Kerry J. Savage; Ranjana H. Advani; Paolo F. Caimi; René-Olivier Casasnovas; Tatyana Feldman; Brian Hess; Mariana Bastos-Oreiro
errShare
errSave
Loncastuximab tesirine in previously treated diffuse large B-cell lymphoma: A plain language summary of the LOTIS-2 study
err2024-11-12
err1
errOAAI
errHamadani, Mehdi; Caimi, Paolo F.; Hess, Brian; Radford, John; Solh, Melhem; Zinzani, Pier Luigi; Wang, Luqiang; Xu, Zhiying Cindy; Carlo-Stella, Carmelo
errShare
errSave
Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial
err2023-12-28
err2
errOAAI
errHamadani, Mehdi; Spira, Alexander; Zhou, Xiaolei; Liao, Laura; Chen, Lei; Radford, John; Ai, Weiyun; Solh, Melhem; Ardeshna, Kirit M.; Hess, Brian; Caimi, Paolo F.; Stathis, Anastasios; Carlo-Stella, Carmelo; Alderuccio, Juan Pablo; Kahl, Brad; Wang, Ying; Qin, Yajuan; Xu, Zhiying Cindy; Zinzani, Pier Luigi
errShare
errSave
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial
err2023-11-21
err16
errOAAI
errHenriksen, Peter A.; Hall, Peter; MacPherson, Iain R.; Joshi, Shruti S.; Singh, Trisha; Maclean, Morag; Lewis, Steff; Rodriguez, Aryelly; Fletcher, Alex; Everett, Russell J.; Stavert, Harriet; Broom, Angus; Eddie, Lois; Primrose, Lorraine; McVicars, Heather; McKay, Pam; Borley, Annabel; Rowntree, Clare; Lord, Simon; Collins, Graham; Radford, John; Guppy, Amy; Williams, Michelle C.; Japp, Alan; Payne, John R.; Newby, David E.; Mills, Nicholas L.; Oikonomidou, Olga; Lang, Ninian N.
errShare
errSave
Pilot study of lung cancer screening for survivors of Hodgkin lymphoma
err2023-11-16
err2
errOAAI
errBroadbent, Rachel; Crosbie, Philip; Armitage, Christopher J.; Taylor, Ben; Tenant, Sean; Mercer, Joseph; Radford, John; Linton, Kim
errShare
errSave
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
err2023-10-19
err4
errOAAI
errAlderuccio, Juan Pablo; Reis, Isildinha M.; Hamadani, Mehdi; Nachiappan, Muthiah; Leslom, Salman; Kahl, Brad S.; Ai, Weiyun Z.; Radford, John; Solh, Melhem; Ardeshna, Kirit M.; Hess, Brian T.; Lunning, Matthew A.; Zinzani, Pier Luigi; Stathis, Anastasios; Carlo-Stella, Carmelo; Lossos, Izidore S.; Caimi, Paolo F.; Han, Sunwoo; Yang, Fei; Kuker, Russ A.; Moskowitz, Craig H.
errShare
errSave
Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study
err2023-08-31
err28
errOAAI
errCaimi, Paolo F.; Ai, Weiyun Z.; Alderuccio, Juan Pablo; Ardeshna, Kirit M.; Hamadani, Mehdi; Hess, Brian; Kahl, Brad S.; Radford, John; Solh, Melhem; Stathis, Anastasios; Zinzani, Pier Luigi; Wang, Ying; Qin, Yajuan; Wang, Luqiang; Xu, Zhiying Cindy; Stella, Carmelo Carlo-
errShare
errSave
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network
err2023-08-28
err0
errOAAI
errHapgood, Greg; Civallero, Monica; Stepanishyna, Yana; Vose, Julie; Cabrera, Monica Elena; Advani, Ranjana H.; Pileri, Stefano A.; Manni, Martina; Horwitz, Steven M.; Foss, Francine M.; Hitz, Felicitas; Radford, John; Dlouhy, Ivan; Chiattone, Carlos; Kim, Won Seog; Skrypets, Tetiana; Nagler, Arnon; Trotman, Judith; Luminari, Stefano; Federico, Massimo
errShare
errSave
The iR2 regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: a multicentre, non-randomised, open-label phase 2 study
err2023-02-01
err12
errOAAI
errRamchandren, Radhakrishnan; Johnson, Peter; Ghosh, Nilanjan; Ruan, Jia; Ardeshna, Kirit M.; Johnson, Roderick; Verhoef, Gregor; Cunningham, David; de Vos, Sven; Kassam, Shireen; Fayad, Luis; Radford, John; Bailly, Sarah; Offner, Fritz; Morgan, David; Munoz, Javier; Ping, Jerry; Szafer-Glusman, Edith; Eckert, Karl; Neuenburg, Jutta K.; Goy, Andre
errShare
errSave
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
err2022-10-20
err22
errOAAI
errGhione, Paola; Palomba, Maria Lia; Ghesquieres, Herve; Bobillo, Sabela; Patel, Anik R.; Nahas, Myrna; Kanters, Steve; Deighton, Kevin; Hatswell, Anthony; Ma, Long; Oldfield, Eve H. Limbrick-; Snider, Julia Thornton; Wade, Sally W.; Riberio, Maria Teresa; Radford, John; Beygi, Sara; Gribben, John
errShare
errSave
Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study
err2022-08-16
err1
errOAAI
errAlderuccio, Juan P.; Ai, Weiyun Z.; Radford, John; Solh, Melhem; Ardeshna, Kirit M.; Lunning, Matthew A.; Hess, Brian T.; Zinzani, Pier L.; Stathis, Anastasios; Carlo-Stella, Carmelo; Hamadani, Mehdi; Kahl, Brad S.; Ungar, David; Kilavuz, Turk; Yu, Eric; Qin, Yajuan; Caimi, Paolo F.
errShare
errSave
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma
err2022-07-28
err158
errOAAI
errAnsell, Stephen M.; Radford, John; Connors, Joseph M.; Dlugosz-Danecka, Monika; Kim, Won-Seog; Gallamini, Andrea; Ramchandren, Radhakrishnan; Friedberg, Jonathan W.; Advani, Ranjana; Hutchings, Martin; Evens, Andrew M.; Smolewski, Piotr; Savage, Kerry J.; Bartlett, Nancy L.; Eom, Hyeon-Seok; Abramson, Jeremy S.; Dong, Cassie; Campana, Frank; Fenton, Keenan; Puhlmann, Markus; Straus, David J.
errShare
errSave
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity
err2022-07-01
err5
errOAAI
errHenriksen, Peter A.; Hall, Peter; Oikonomidou, Olga; MacPherson, Iain R.; Maclean, Morag; Lewis, Steff; McVicars, Heather; Broom, Angus; Scott, Fiona; McKay, Pam; Borley, Annabel; Rowntree, Clare; Lord, Simon; Collins, Graham; Radford, John; Guppy, Amy; Payne, John R.; Newby, David E.; Mills, Nick L.; Lang, Ninian N.
errShare
errSave
The perspectives of survivors of Hodgkin lymphoma on lung cancer screening: A qualitative study
err2021-11-09
err4
errOAAI
errBroadbent, Rachel; Gorman, Louise; Armitage, Christopher J.; Radford, John; Linton, Kim
errShare
errSave
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study
err2021-10-23
err10
errOAAI
errHawkes, Eliza A.; Phillips, Tycel; Budde, Lihua Elizabeth; Santoro, Armando; Saba, Nakhle S.; Roncolato, Fernando; Gregory, Gareth P.; Verhoef, Gregor; Offner, Fritz; Quero, Cristina; Radford, John; Giannopoulos, Krzysztof; Stevens, Don; Thall, Aron; Huang, Bo; Laird, A. Douglas; Sandner, Robin; Ansell, Stephen M.
errShare
errSave
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial
err2021-09-03
err22
errOAAI
errHerrera, Alex F.; Burton, Catherine; Radford, John; Miall, Fiona; Townsend, William; Santoro, Armando; Zinzani, Pier Luigi; Lewis, David; Fowst, Camilla; Brar, Satjit; Huang, Bo; Thall, Aron; Collins, Graham P.
errShare
errSave
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study
err2021-07-24
err19
PREAI
errKim, Won Seog; Oki, Yasuhiro; Kim, Seok Jin; Yoon, Sang Eun; Ardeshna, Kirit M.; Lin, Yi; Ruan, Jia; Porcu, Pierluigi; Brammer, Jonathan E.; Jacobsen, Eric D.; Yoon, Dok Hyun; Suh, Cheolwon; Suarez, Felipe; Radford, John; Budde, Lihua E.; Kim, Jin Seok; Bachy, Emmanuel; Lee, Hun Ju; Bollard, Catherine M.; Jaccard, Arnaud; Kang, Hye Jin; Inman, Shannon; Murray, Maryann; Combs, Katherin E.; Lee, Daniel Y.; Advani, Ranjana; Gunter, Kurt C.; Rooney, Cliona M.; Heslop, Helen E.
errShare
errSave
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study
err2021-06-24
err40
errOAAI
errEvens, Andrew M.; Connors, Joseph M.; Younes, Anas; Ansell, Stephen M.; Kim, Won Seog; Radford, John; Feldman, Tatyana; Tuscano, Joseph; Savage, Kerry J.; Oki, Yasuhiro; Grigg, Andrew; Pocock, Christopher; Dlugosz-Danecka, Monika; Fenton, Keenan; Forero-Torres, Andres; Liu, Rachael; Jolin, Hina; Gautam, Ashish; Gallamini, Andrea
errShare
errSave
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial
err2021-06-01
err98
PREAI
errStraus, David J.; Dlugosz-Danecka, Monika; Connors, Joseph M.; Alekseev, Sergey; Illes, Arpad; Picardi, Marco; Lech-Maranda, Ewa; Feldman, Tatyana; Smolewski, Piotr; Savage, Kerry J.; Bartlett, Nancy L.; Walewski, Jan; Ramchandren, Radhakrishnan; Zinzani, Pier Luigi; Hutchings, Martin; Munoz, Javier; Lee, Hun Ju; Kim, Won Seog; Advani, Ranjana; Ansell, Stephen M.; Younes, Anas; Gallamini, Andrea; Liu, Rachael; Little, Meredith; Fenton, Keenan; Fanale, Michelle; Radford, John
errShare
errSave